Ferentis is a research-intensive biotechnology company involved in the development, production and commercialisation of biomimetic peptides and peptide-based scaffolds for tissue engineering and regenerative medicine applications. Read more
Ferentis participated in top level Japan-Lithuania business forumOn the occasion of the visit of the Japanese Prime Minister Shinzo Abe to Lithuania on January 13, 2018, Ferentis Business Development Director participated in the business forum hosted by the Government Office of the Republic of Lithuania.More details
